T2 Biothreat Panel
Multiplex Nucleic Acid Detection System For Biothreat Agents. 510(k) K231336, from T2biosystems, Inc. (Lexington, MA). Product code QVR, class 2.
As of Nov 20, 2026, K231336 is an FDA 510(k) held by T2biosystems, Inc., substantially equivalent on Sep 15, 2023 after 130 days, with no recalls tied to it in FDA's recall database.
- Review time: 130 days
- Recalls: 0
The T2Biothreat Panel is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the T2Dx Instrument. The T2Biothreat Panel detects nucleic acids from the following organisms directly from K2EDTA whole blood samples: 1. Bacillus anthracis (plasmids pXO1 and pXO2) 2. Francisella tularensis 3. Burkholderia spp. (B. mallei/B. pseudomallei) 4. Yersinia pestis 5.
- FilmArray NGDS Warrior PanelK170883 · Biofire Defense, LLC · Jun 22, 2017
- Xpert® Hemorrhagic Fever PanelK262971 · Cepheid · Oct 30, 2026
- BioFire Global Fever Special Pathogens Panel; BIOFIRE SHIELD Control Kit for the BioFire Global Fever Special Pathogens…K213362 · Biofire Defense, LLC · Mar 22, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 8, 2023
- Review panel
- Immunology
- Regulation
- 21 CFR 866.4000
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files